Hyperglycemia is the main mediator of prediabetes- and type 2 diabetes-associated impairment of microvascular function: the Maastricht Study

B.M. Sorensen; A.J.H.M. Houben; T.T.J.M. Berendschot; J.S.A.G. Schouten; A.A. Kroon; C.J.H. van der Kallen; R.M.A. Henry; A. Koster; K.D. Reesink; P.C. Dagnelie; N.C. Schaper; C.G. Schalkwijk; M.T. Schram; C.D.A. Stehouwer

doi:10.2337/dc17-0574

Hyperglycemia is the main mediator of prediabetes- and type 2 diabetes-associated impairment of microvascular function: the Maastricht Study

B.M. Sorensen, A.J.H.M. Houben, T.T.J.M. Berendschot, J.S.A.G. Schouten, A.A. Kroon, C.J.H. van der Kallen, R.M.A. Henry, A. Koster, K.D. Reesink, P.C. Dagnelie, N.C. Schaper, C.G. Schalkwijk, M.T. Schram, C.D.A. Stehouwer

Medical Image Analysis

Research output: Contribution to journal › Article › Academic › peer-review

14 Citations (Scopus)

120 Downloads (Pure)

Original language	English
Pages (from-to)	E103-E105
Journal	Diabetes Care
Volume	40
Issue number	8
DOIs	https://doi.org/10.2337/dc17-0574
Publication status	Published - 1 Aug 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/dc17-0574

author versionFinal author version , 535 KB

Cite this

Sorensen, B. M., Houben, A. J. H. M., Berendschot, T. T. J. M., Schouten, J. S. A. G., Kroon, A. A., van der Kallen, C. J. H., Henry, R. M. A., Koster, A., Reesink, K. D., Dagnelie, P. C., Schaper, N. C., Schalkwijk, C. G., Schram, M. T., & Stehouwer, C. D. A. (2017). Hyperglycemia is the main mediator of prediabetes- and type 2 diabetes-associated impairment of microvascular function: the Maastricht Study. Diabetes Care, 40(8), E103-E105. https://doi.org/10.2337/dc17-0574

@article{f9586afb4a284da3b9e0995d2dbae13a,

title = "Hyperglycemia is the main mediator of prediabetes- and type 2 diabetes-associated impairment of microvascular function: the Maastricht Study",

author = "B.M. Sorensen and A.J.H.M. Houben and T.T.J.M. Berendschot and J.S.A.G. Schouten and A.A. Kroon and {van der Kallen}, C.J.H. and R.M.A. Henry and A. Koster and K.D. Reesink and P.C. Dagnelie and N.C. Schaper and C.G. Schalkwijk and M.T. Schram and C.D.A. Stehouwer",

year = "2017",

month = aug,

day = "1",

doi = "10.2337/dc17-0574",

language = "English",

volume = "40",

pages = "E103--E105",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "8",

}

Sorensen, BM, Houben, AJHM, Berendschot, TTJM, Schouten, JSAG, Kroon, AA, van der Kallen, CJH, Henry, RMA, Koster, A, Reesink, KD, Dagnelie, PC, Schaper, NC, Schalkwijk, CG, Schram, MT & Stehouwer, CDA 2017, 'Hyperglycemia is the main mediator of prediabetes- and type 2 diabetes-associated impairment of microvascular function: the Maastricht Study', Diabetes Care, vol. 40, no. 8, pp. E103-E105. https://doi.org/10.2337/dc17-0574

TY - JOUR

T1 - Hyperglycemia is the main mediator of prediabetes- and type 2 diabetes-associated impairment of microvascular function: the Maastricht Study

AU - Sorensen, B.M.

AU - Houben, A.J.H.M.

AU - Berendschot, T.T.J.M.

AU - Schouten, J.S.A.G.

AU - Kroon, A.A.

AU - van der Kallen, C.J.H.

AU - Henry, R.M.A.

AU - Koster, A.

AU - Reesink, K.D.

AU - Dagnelie, P.C.

AU - Schaper, N.C.

AU - Schalkwijk, C.G.

AU - Schram, M.T.

AU - Stehouwer, C.D.A.

PY - 2017/8/1

Y1 - 2017/8/1

UR - http://www.scopus.com/inward/record.url?scp=85028048929&partnerID=8YFLogxK

U2 - 10.2337/dc17-0574

DO - 10.2337/dc17-0574

M3 - Article

C2 - 28626010

SN - 0149-5992

VL - 40

SP - E103-E105

JO - Diabetes Care

JF - Diabetes Care

IS - 8

ER -

Hyperglycemia is the main mediator of prediabetes- and type 2 diabetes-associated impairment of microvascular function: the Maastricht Study

UN SDGs

Access to Document

Other files and links

Cite this